WNT4 mediates estrogen receptor signaling and endocrine resistance in invasive lobular carcinoma cell lines

BACKGROUND: Invasive lobular carcinoma (ILC) of the breast typically presents with clinical biomarkers consistent with a favorable response to endocrine therapies, and over 90 % of ILC cases express the estrogen receptor (ER). However, a subset of ILC cases may be resistant to endocrine therapies, s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Breast Cancer Res
Autors principals: Sikora, Matthew J., Jacobsen, Britta M., Levine, Kevin, Chen, Jian, Davidson, Nancy E., Lee, Adrian V., Alexander, Caroline M., Oesterreich, Steffi
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5028957/
https://ncbi.nlm.nih.gov/pubmed/27650553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-016-0748-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars